Elon Musk’s brain-chip startup, Neuralink, has earned the US Food and Drug Administration’s “breakthrough device” designation for its experimental implant, Blindsight. This device is intended to restore vision for individuals with total or partial blindness, including those with non-functional optic nerves.
“We have received Breakthrough Device Designation from the FDA for Blindsight.
“Join us in our quest to bring back sight to those who have lost it. Apply to our Patient Registry and openings on our career page,” Neuralink wrote on its X page on Tuesday.
Reuters reports that the FDA grants its breakthrough designation to medical devices aimed at treating or diagnosing life-threatening conditions, accelerating their development and review process.
Musk shared the news on his X social media platform, emphasizing Blindsight’s potential to restore vision even in the most severe cases of blindness.
“The Blindsight device from Neuralink will enable even those who have lost both eyes and their optic nerve to see.
“Provided the visual cortex is intact, it will even enable those who have been blind from birth to see for the first time.
“To set expectations correctly, the vision will be at first be low resolution, like Atari graphics, but eventually it has the potential to be better than natural vision and enable you to see in infrared, ultraviolet or even radar wavelengths, like Geordi La Forge.” Musk wrote on X.com.
Neuralink, co-founded by Elon Musk in 2016, focuses on developing cutting-edge brain-computer interfaces aimed at revolutionizing treatments for neurological disorders.
Its technology features a brain implant that interprets neural signals and transmits them wirelessly to external devices like computers and smartphones.
According to Business World, Neuralink is also creating an implant that allows paralyzed individuals to control digital devices with their thoughts.
The company is currently conducting a clinical trial with three participants to assess the implant’s effectiveness in helping those with spinal cord injuries.
In August 2024, reports confirmed that Neuralink’s brain-computer interface was successfully implanted in a second patient, who is now using their thoughts to control video games and design 3D objects.
……….
Note : To submit Press Releases, Statements, and Advert Inquiries for publication on Waffi blog (website) or Television 📺, please use the following contact details: You can send an email to info@waffitv.com or reach us via Whatsapp at 07068286500
